Abstract
Background: The leaves of Annona reticulata Linn. have been traditionally used by the tribes of Assam as a source of medicine to mitigate a range of health ailments, including diabetes and obesity.
Objectives: The current study aimed to evaluate the anti-diabetic and anti-hyperlipidemic potential of bioactive fractions isolated from the methanolic extract of Annona reticulata Linn. leaves using Nicotinamide + Streptozotocin (60 mg/kg, i.p.) induced diabetic rats.
Methods: The partially purified bioactive fractions, namely F1, F2, F3 and F4 were administered to diabetic rats with a dose of 200 mg/kg, per oral (p.o.) and the effect of the fractions on serum glucose was studied up to 21 days. The potent fractions were further subjected to spectral analysis for the identification of the isolated active compounds.
Results: The in-vivo anti-diabetic activity of the isolated fractions F2 and F3 was found significant controlling blood glucose level, alike glibenclamide. Interestingly, F2 and F3 treated animals were found significant in restoring the lipid and liver enzymes profile in streptozotocin challenge rats. Further, spectral analysis revealed that F2 and F3 were comprised of Quercetin and Gallic acid, respectively.
Conclusion: The outcome of finding demonstrates the anti-diabetic and anti-hyperlipidemic potential of the isolates/fractions of A. reticulata, which were found enriched in polyphenolics, including Quercetin and Gallic acid; and provided logistic behind the traditional use of the A. reticulata against diabetes and obesity.
Keywords: Annona reticulata, diabetes mellitus, streptozotocin, glibenclamide, quercetin and gallic acid.
The Natural Products Journal
Title:Evaluation of Anti-Diabetic and Anti-Hyperlipidemic Activity of Isolated Bioactive Compounds of Leaves of Annona reticulata Linn.
Volume: 11 Issue: 3
Author(s): Kalyani Pathak*, Aparoop Das, Anshul Shakya, Riya Saikia and Himangshu Sarma
Affiliation:
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam,India
Keywords: Annona reticulata, diabetes mellitus, streptozotocin, glibenclamide, quercetin and gallic acid.
Abstract:
Background: The leaves of Annona reticulata Linn. have been traditionally used by the tribes of Assam as a source of medicine to mitigate a range of health ailments, including diabetes and obesity.
Objectives: The current study aimed to evaluate the anti-diabetic and anti-hyperlipidemic potential of bioactive fractions isolated from the methanolic extract of Annona reticulata Linn. leaves using Nicotinamide + Streptozotocin (60 mg/kg, i.p.) induced diabetic rats.
Methods: The partially purified bioactive fractions, namely F1, F2, F3 and F4 were administered to diabetic rats with a dose of 200 mg/kg, per oral (p.o.) and the effect of the fractions on serum glucose was studied up to 21 days. The potent fractions were further subjected to spectral analysis for the identification of the isolated active compounds.
Results: The in-vivo anti-diabetic activity of the isolated fractions F2 and F3 was found significant controlling blood glucose level, alike glibenclamide. Interestingly, F2 and F3 treated animals were found significant in restoring the lipid and liver enzymes profile in streptozotocin challenge rats. Further, spectral analysis revealed that F2 and F3 were comprised of Quercetin and Gallic acid, respectively.
Conclusion: The outcome of finding demonstrates the anti-diabetic and anti-hyperlipidemic potential of the isolates/fractions of A. reticulata, which were found enriched in polyphenolics, including Quercetin and Gallic acid; and provided logistic behind the traditional use of the A. reticulata against diabetes and obesity.
Export Options
About this article
Cite this article as:
Pathak Kalyani *, Das Aparoop , Shakya Anshul , Saikia Riya and Sarma Himangshu , Evaluation of Anti-Diabetic and Anti-Hyperlipidemic Activity of Isolated Bioactive Compounds of Leaves of Annona reticulata Linn., The Natural Products Journal 2021; 11 (3) . https://dx.doi.org/10.2174/2210315510999200511132940
DOI https://dx.doi.org/10.2174/2210315510999200511132940 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?
Current Medicinal Chemistry Can 5-HT3 Receptor Antagonists Replace Anesthetics and Corticosteroids in the Local Treatment of Rheumatic Processes?
Current Rheumatology Reviews Insulin Delivery Systems for Controlling Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) From Gene to Epigene-Based Therapies Targeting the Vascular Endothelium
Current Vascular Pharmacology Insight into the Epigenetics of Alzheimer's Disease: A Computational Study from Human Interactome
Current Alzheimer Research Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem Cell-Based Therapy for Severe Autoimmune Disorders
Epigenetic Diagnosis & Therapy (Discontinued) Cilostazol: A New Drug in the Treatment Intermittent Claudication
Recent Patents on Cardiovascular Drug Discovery Potential of Gentiana lutea for the Treatment of Obesity-associated Diseases
Current Pharmaceutical Design Mechanisms of Drug Induced QT Interval Prolongation
Current Drug Safety Ezetimibe Therapy for Dyslipidemia: An Update
Current Pharmaceutical Design Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion
Combinatorial Chemistry & High Throughput Screening Vascular Disease: A New Progenitor Biology
Current Vascular Pharmacology Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
Current Pharmaceutical Design A Proposal for a New Classification of Type 1 Diabetes Mellitus Based on Clinical and Immunological Evidence
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) β-cell Regenerative Potential of Selected Herbal Extracts in Alloxan Induced Diabetic Rats
Current Drug Discovery Technologies Alternative Use of Bisphosphonate Therapy for Rheumatic Disease
Current Pharmaceutical Design Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Exercise in Youth with Type 1 Diabetes
Current Pediatric Reviews